NVAX
Novavax Inc
NASDAQ: NVAX · HEALTHCARE · BIOTECHNOLOGY
$7.93
-0.56% today
Updated 2026-04-30
Market cap
$1.31B
P/E ratio
3.09
P/S ratio
1.17x
EPS (TTM)
$2.58
Dividend yield
—
52W range
$6 – $12
Volume
4.2M
Novavax Inc (NVAX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+99.0%
Last 4 quarters
Revenue YoY growth
+66.6%
Most recent quarter
EPS YoY growth
+121.2%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+10.8%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+30.5%
2025-08-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-04 | $0.11 | +126.2% | $9.49 | $9.99 | +5.3% |
| 2025-11-06 | $-1.25 | -130.3% | $7.69 | $7.44 | -3.3% |
| 2025-08-06 | $0.62 | +1133.3% | $6.73 | $8.78 | +30.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.42 | $0.11 | +126.2% | $147.14M | +66.6% |
| 2025-09-30 | $-0.54 | $-1.25 | -130.3% | $70.44M | -16.6% |
| 2025-06-30 | $-0.06 | $0.62 | +1133.3% | $239.24M | -42.4% |
| 2025-03-31 | $0.71 | $2.93 | +313.5% | $666.65M | +610.3% |
| 2024-12-31 | $-0.51 | $-0.52 | -1.2% | $88.31M | -69.7% |
| 2024-09-30 | $-0.83 | $-0.76 | +8.7% | $84.51M | +283.0% |
| 2024-06-30 | $1.64 | $0.99 | -39.6% | $415.48M | -2.1% |
| 2024-03-31 | $-1.06 | $-1.05 | +0.9% | $93.86M | -1560.1% |
| 2023-12-31 | $-0.45 | $-1.44 | -220.0% | $291.34M | — |
| 2023-09-30 | $-1.83 | $-1.26 | +31.1% | $22.06M | — |
| 2023-06-30 | $-1.39 | $0.58 | +141.7% | $424.43M | — |
| 2023-03-31 | $-3.46 | $-3.41 | +1.4% | $-6.43M | — |
Frequently asked questions
Has Novavax Inc beaten earnings estimates?
Novavax Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +99.0% over the last 4 quarters.
How does NVAX stock react to earnings?
NVAX stock has moved an average of +10.8% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Novavax Inc's revenue growth rate?
Novavax Inc reported year-over-year revenue growth of +66.6% in its most recent quarter, with EPS growing +121.2% year-over-year.